Relay Therapeutics, Inc. (RLAY) Debt-to-equity % [USD] 2021 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Relay Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from 2021 to 2024.
  • Relay Therapeutics, Inc. Debt-to-equity for the quarter ending March 31, 2024 was 15.2 %, a 5.89% decline year-over-year.
Debt-to-equity, Quarterly (% [USD])
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 15.2 -0.95 -5.89% Mar 31, 2024
Q4 2023 16.3 +1.32 +8.79% Dec 31, 2023
Q3 2023 17.1 +2.94 +20.8% Sep 30, 2023
Q2 2023 17.1 +3.26 +23.5% Jun 30, 2023
Q1 2023 16.1 +1.96 +13.8% Mar 31, 2023
Q4 2022 15 +2.76 +22.5% Dec 31, 2022
Q3 2022 14.1 +4.02 +39.8% Sep 30, 2022
Q2 2022 13.9 +6.48 +87.6% Jun 30, 2022
Q1 2022 14.2 +6.66 +88.8% Mar 31, 2022
Q4 2021 12.3 Dec 31, 2021
Q3 2021 10.1 Sep 30, 2021
Q2 2021 7.39 Jun 30, 2021
Q1 2021 7.5 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.